INVO Bioscience SG&A Expense (Quarterly) Trends

INVO Bioscience Inc (INVO)

0.88 -0.02 (-1.86%) USD | NASDAQ | May 31, 16:00

0.866 -0.01 (-1.59%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	1.441M
December 31, 2023	1.856M
September 30, 2023	1.257M
June 30, 2023	2.043M
March 31, 2023	2.331M
December 31, 2022	2.668M
September 30, 2022	2.317M
June 30, 2022	2.445M
March 31, 2022	2.694M
December 31, 2021	2.434M
September 30, 2021	2.417M
June 30, 2021	2.049M
March 31, 2021	2.115M
December 31, 2020	1.753M
September 30, 2020	1.464M
June 30, 2020	1.253M
March 31, 2020	1.595M
December 31, 2019	1.041M
September 30, 2019	0.891M
June 30, 2019	0.6692M
March 31, 2019	0.5276M
December 31, 2018	0.6246M
September 30, 2018	0.2995M
June 30, 2018	1.884M
March 31, 2018	0.23M

Date	Value
December 31, 2017	0.2673M
September 30, 2017	0.1997M
June 30, 2017	0.1985M
March 31, 2017	0.2051M
December 31, 2016	0.2767M
September 30, 2016	0.2187M
June 30, 2016	1.455M
March 31, 2016	0.1956M
December 31, 2015	0.2354M
September 30, 2015	0.1169M
June 30, 2015	0.1135M
March 31, 2015	0.1333M
December 31, 2011	0.1541M
September 30, 2011	0.1821M
June 30, 2011	0.22M
March 31, 2011	0.201M
December 31, 2010	0.4337M
September 30, 2010	0.3633M
June 30, 2010	0.3176M
March 31, 2010	0.4466M
December 31, 2009	0.4623M
September 30, 2009	0.2936M
June 30, 2009	0.4441M
March 31, 2009	0.6569M
December 31, 2008	1.797M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.6692M

Minimum

Jun 2019

2.694M

Maximum

Mar 2022

1.837M

Average

1.949M

Median

SG&A Expense (Quarterly) Benchmarks